Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stride (LRN) Research & Development (2016 - 2019)

Stride (LRN) has disclosed Research & Development for 10 consecutive years, with $2.6 million as the latest value for Q2 2019.

  • On a quarterly basis, Research & Development rose 29.97% to $2.6 million in Q2 2019 year-over-year; TTM through Jun 2019 was $9.5 million, a 2.5% increase, with the full-year FY2019 number at $2.6 million, up 29.97% from a year prior.
  • Research & Development was $2.6 million for Q2 2019 at Stride, up from $2.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $4.3 million in Q2 2015 to a low of $1.1 million in Q2 2016.
  • A 5-year average of $2.7 million and a median of $2.9 million in 2016 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: crashed 75.28% in 2016, then surged 182.19% in 2017.
  • Stride's Research & Development stood at $3.0 million in 2015, then dropped by 5.12% to $2.9 million in 2016, then dropped by 17.3% to $2.4 million in 2017, then plummeted by 54.97% to $1.1 million in 2018, then soared by 139.53% to $2.6 million in 2019.
  • Per Business Quant, the three most recent readings for LRN's Research & Development are $2.6 million (Q2 2019), $2.3 million (Q1 2019), and $1.1 million (Q4 2018).